Swarm was formed in 2022 and has now emerged with Martin Olin – previously chief executive of BerGenBio and Symphogen – at ...
These cells present the antigens to T cells, effectively "priming" them to recognize cancer cells as targets. Once activated in the lymph nodes, T cells travel to the tumor site to destroy it ...
12 天
News Medical on MSNTerumo Blood and Cell Technologies and FUJIFILM Irvine Scientific collaborate to accelerate ...Terumo Blood and Cell Technologies (Terumo BCT) and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV ® T Cell Expansion ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果